- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT01239784
Neurodevelopmental Rehabilitation for Toddlers With Complex Heart Defects
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
Neurodevelopmental deficits are a common morbidity among children who receive surgical treatment for complex congenital heart defects in infancy. Over 40% of children with complex heart defects will have neurodevelopmental deficits that persist throughout childhood even after a successful surgical procedure in infancy1. These deficits are typically related to basic motor perceptual motor or visual motor skills. Problems integrating what is seen (visual perceptions) with body movement (motor skills) makes it difficult for children to participate in peer play and limits their ability to succeed in school, thereby having a significant impact on the child's quality of life.
Traditional, therapist-delivered rehabilitation programmes to address these delays in neurodevelopment have not previously been attempted. It would be difficult to provide direct rehabilitation programmes to these patients given that their defects are rare and few patients are located within the same geographical area. Home-based, parent-delivered rehabilitation programmes have previously been shown to be effective at improving the motor skills of school-age children with complex heart defects5. Since a home-based parent delivered model would enable the participation of infants regardless of geographic location, the feasibility of using such a model for delivering neurodevelopmental rehabilitation should be investigated.
Type d'étude
Inscription (Réel)
Phase
- Phase 2
Contacts et emplacements
Lieux d'étude
-
-
Ontario
-
Toronto, Ontario, Canada, M5G 1X8
- The Hospital for Sick Children
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
Families will be eligible to participate in this study if the child:
- Had the arterial switch operation (for transposition of the great arteries) or has had a Glenn procedure (for functional single ventricle).
- Is medically stable for normal infant activities.
- Is between 12 and 24 months of age in January 2010.
Exclusion Criteria:
Families will be excluded from study participation if:
- The child has a recognized syndrome or other disability affecting neurodevelopment.
- The child has had a medical procedure in the 3 months preceding the baseline study assessment.
- The cardiologist responsible for the child's care refuses to allow the child's participation.
- The child performs substantially above age-appropriate developmental milestones during the initial assessment (in which case an intervention is unlikely to have a detectable additional benefit).
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Soins de soutien
- Répartition: N / A
- Modèle interventionnel: Affectation à un seul groupe
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: All Subjects
A total of 20 children and their parents will be recruited for this study.
Ten children will have had the Glenn procedure and 10 infants will have had the arterial switch operation.
|
Participation in the study will require the parent and child to attend two assessment visits in addition to completing a series of parent and infant activities on a daily basis throughout the 10-week intervention period.
The parent-led activities will include activities such as walking with the child, stacking blocks, rolling a ball to the child, hiding a toy under a blanket for the child to find, encouraging the child to kick a rattle while the child is lying on his/her back, or crawling or rolling in different directions.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change from baseline in child's neurodevelopmental status at four months using the Peabody Development Motor Scales
Délai: Baseline and four months
|
The Peabody Development Motor Scale has demonstrated validity and reliability for children from birth to 5 years of age.
Six subtests (reflexes, stationary, locomotion, object manipulation, grasping, visual-motor integration) yield gross, fine and total motor quotient scores.
|
Baseline and four months
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Parents opinion on the home-based neurodevelopmental rehabilitation programme
Délai: at 4 months
|
During the final assessment, the researcher will interview the parent to obtain their perspective on delivering the study activities at home.
|
at 4 months
|
|
Research students experience and perception of guiding a home-based, parent-delivered rehabilitation programme
Délai: at 4 months
|
Research students participating in this project will also be interviewed regarding their experiences and perceptions of guiding a home-based, parent-delivered rehabilitation programme.
|
at 4 months
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Brian McCrindle, MD, The Hospital for Sick Children, Toronto Canada
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Estimation)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Autres numéros d'identification d'étude
- 1000014278
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .
Essais cliniques sur Malformations cardiaques
-
Region SkaneInscription sur invitationInsuffisance cardiaque New York Heart Association (NYHA) Classe II | Insuffisance cardiaque Classe III de la New York Heart Association (NYHA)Suède
-
Medical University of BialystokMedical University of Lodz; Poznan University of Medical Sciences; Nicolaus... et autres collaborateursRésiliéInsuffisance cardiaque, systolique | Insuffisance cardiaque avec fraction d'éjection réduite | Insuffisance cardiaque New York Heart Association Classe IV | Insuffisance cardiaque Classe III de la New York Heart AssociationPologne
-
University of WashingtonAmerican Heart AssociationComplétéInsuffisance cardiaque, congestive | Altération mitochondriale | Insuffisance cardiaque New York Heart Association Classe IVÉtats-Unis
-
Portuguese Association of Interventional CardiologyMedtronicRecrutementSténose aortique symptomatique sévère (définie comme classe ≥ II de la New York Heart Association (NYHA))Le Portugal
Essais cliniques sur Home-based neurodevelopmental rehabilitation programme
-
University Hospital, BordeauxPas encore de recrutement
-
University of PlymouthPas encore de recrutementMaladie de Parkinson | ParkinsonRoyaume-Uni
-
Indiana UniversityRecrutement
-
Dartmouth-Hitchcock Medical CenterUnited States Department of DefenseActif, ne recrute pasLésions cérébrales, traumatiques | Épilepsie, TraumatiqueÉtats-Unis